Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: A Singapore healthcare perspective
10.11622/smedj.2013045
Saved in:
Main Authors: | Chin, C.T., Mellstrom, C., Chua, T.S.J., Matchar, D.B. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110574 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Switching from Ticagrelor to Clopidogrel in Asian Patients with ST-Elevated Myocardial Infarction – A Time Dependent Analysis Study
by: Koh L, et al.
Published: (2020) -
Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
by: Zhao, YJ, et al.
Published: (2021) -
Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI)
by: Park, Y, et al.
Published: (2021) -
Clinical predictors of a positive troponin T test in patients presenting with probable acute coronary syndromes
by: ABDUL RAZAKJR BIN OMAR, et al.
Published: (2016) -
Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation
by: Yip, Christina, et al.
Published: (2021)